Drug Research
Arranta Bio, MIT Partner to Develop Rapid Manufacturing of mRNA Therapeutics
Arranta Bio, part of Recipharm’s biologics business, has signed a contract with MIT to develop a continuous manufacturing technology for mRNA therapeutics. The contract is...
Drug Research
Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID
Charles River Laboratories International, Inc announced the launch of Accugenix® Next Generation Sequencing for Bacterial Identification and Fungal Identification. Accugenix NGS simultaneously sequences millions of...
Drug Research
US FDA approves Pfizer’s 20-valent Pneumococcal Conjugate Vaccine for children
Pfizer Inc. announced that the U.S. FDA has approved PREVNAR 20 (20-valent Pneumococcal Conjugate Vaccine) for the prevention of invasive pneumococcal disease (IPD) caused by...
Drug Research
A Research Established To Address Antimicrobial Resistance
Global research consortium is being set up to address the international impact of antimicrobial resistance (AMR). Significantly, the Centres for Antimicrobial Optimisation Network- CAMO-Net brings...
Drug Research
Gene Scissors Cramp-Up Viral Infections Within Human Cells
It is still difficult to get to the bottom of viral illnesses. Although isolated medicines exist that block virus multiplication in human cells, they are...
Drug Research
Biotech Research Funding In Australia Witnesses A Low Phase
Research co-led by the University of Queensland has found that Australia is falling short of similar countries when it comes to funding basic research, specifically...
Drug Research
Matrix-M, Saponin-Based Adjuvant Boosts Malarial Immunity
R21/Matrix-M happens to have a saponin-based adjuvant, Matrix-M, which goes on to enhance the immune response, thereby making it more viable and also durable.
It is...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.